| Literature DB >> 35659338 |
Yan Chen1, Xu-Dong Ma2, Xiao-Hui Kang1, Si-Fa Gao2, Jin-Min Peng1, Shan Li1, Da-Wei Liu3, Xiang Zhou4, Li Weng5, Bin Du6.
Abstract
BACKGROUND: The burden of sepsis remains high in China. The relationship between case volume and hospital mortality among patients with septic shock, the most severe complication of sepsis, is unknown in China.Entities:
Keywords: Case volume; Hospital mortality; Septic shock
Mesh:
Year: 2022 PMID: 35659338 PMCID: PMC9166431 DOI: 10.1186/s13054-022-04035-8
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 19.334
Characteristics of septic shock cases and enrolled hospitals and intensive care units
| Septic shock case volume quartile | |||||
|---|---|---|---|---|---|
| First quartile, 1–13 cases per year | Second quartile, 14–32 cases per year | Third quartile, 33–75 cases per year | Fourth quartile, > 75 cases per year | ||
| Number of hospitals, | 475 | 468 | 478 | 481 | |
| Geographic location, | 0.763 | ||||
| East | 193 (40) | 179 (38) | 191 (39) | 204 (42) | |
| Middle | 102 (21) | 118 (25) | 104 (21) | 114 (23) | |
| West | 158 (33) | 150 (32) | 162 (33) | 136 (28) | |
| Northeast | 22 (4) | 21 (4) | 21 (4) | 27 (5) | |
| Type of hospitals, | 0.001 | ||||
| Public | 432 (91) | 430 (92) | 440 (92) | 466 (97) | |
| Private | 43 (9) | 38 (8) | 38 (8) | 15 (3) | |
| Level of hospitals, | < 0.0001 | ||||
| Tertiary | 139 (29) | 226 (48) | 277 (57) | 388 (80) | |
| Secondary | 331 (69) | 238 (50) | 199 (41) | 91 (18) | |
| Healthcare facility volume, | |||||
| Hospital volume per year | 18,616 ± 16,069 | 26,460 ± 27,795 | 34,297 ± 28,557 | 60,618 ± 55,195 | < 0.0001 |
| ICU volume per year | 414 ± 1509 | 597 ± 2337 | 641 ± 586 | 1463 ± 2119 | < 0.0001 |
| Hospital bed days/1000 patients | 153 ± 102 | 224 ± 211 | 331 ± 1036 | 522 ± 1144 | < 0.001 |
| ICU bed days/1000 patients | 3 ± 13 | 3 ± 4 | 6 ± 33 | 11 ± 37 | < 0.0001 |
| Guideline compliance, % | |||||
| 3-h Surviving Sepsis Campaign bundle | 73 ± 32 | 79 ± 25 | 78 ± 25 | 78 ± 24 | 0.004 |
| 6-h Surviving Sepsis Campaign bundle | 71 ± 33 | 77 ± 27 | 77 ± 27 | 76 ± 24 | 0.002 |
| Microbiology specimen collection before antibiotic therapy, % | 68 ± 34 | 75 ± 27 | 77 ± 29 | 80 ± 24 | < 0.001 |
| Protocolized Infection control, | |||||
| Infection management | 434 (91) | 448 (96) | 466 (97) | 467 (97) | < 0.001 |
| Infection training | 433 (91) | 433 (93) | 459 (96) | 467 (97) | < 0.001 |
| Infection monitor | 435 (92) | 439 (94) | 466 (97) | 472 (98) | < 0.001 |
| Infection contingency plan | 443 (93) | 445 (95) | 467 (98) | 471 (98) | < 0.001 |
| Infection performance | 318 (67) | 325 (70) | 363 (76) | 350 (73) | 0.015 |
| ICU mortality rate, % | 11 ± 10 | 12 ± 10 | 12 ± 10 | 12 ± 9 | 0.530 |
| Female, % | 45 ± 20 | 40 ± 11 | 40 ± 10 | 41 ± 9 | < 0.0001 |
| Age group, % | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | |
| Less than 18 years old | 3 ± 15 | 2 ± 10 | 3 ± 13 | 2 ± 8 | 0.263 |
| 18–30 years old | 3 ± 13 | 2 ± 4 | 3 ± 4 | 3 ± 4 | 0.027 |
| 31–40 years old | 4 ± 11 | 4 ± 6 | 5 ± 6 | 6 ± 5 | < 0.0001 |
| 41–50 years old | 8 ± 14 | 9 ± 9 | 10 ± 8 | 10 ± 6 | < 0.0001 |
| 51–60 years old | 15 ± 18 | 16 ± 11 | 17 ± 10 | 17 ± 8 | 0.070 |
| 61–70 years old | 25 ± 22 | 25 ± 13 | 25 ± 11 | 23 ± 9 | 0.062 |
| 71–80 years old | 26 ± 23 | 24 ± 13 | 23 ± 12 | 23 ± 11 | 0.016 |
| More than 80 years old | 18 ± 22 | 18 ± 15 | 16 ± 14 | 15 ± 11 | 0.026 |
| Site of infection, % | |||||
| Bloodstream | 16 ± 26 | 17 ± 21 | 16 ± 20 | 15 ± 15 | 0.850 |
| Catheter related bloodstream | 4 ± 12 | 5 ± 10 | 3 ± 7 | 3 ± 5 | 0.043 |
| Lung | 44 ± 31 | 42 ± 22 | 41 ± 23 | 41 ± 22 | 0.294 |
| Abdomen | 18 ± 22 | 17 ± 14 | 18 ± 14 | 16 ± 11 | 0.113 |
| Urinary tract | 14 ± 20 | 12 ± 11 | 13 ± 11 | 12 ± 9 | 0.378 |
| Central nervous system | 2 ± 9 | 2 ± 4 | 2 ± 3 | 3 ± 4 | 0.043 |
| Biliary tract | 7 ± 14 | 7 ± 7 | 7 ± 6 | 7 ± 6 | 0.720 |
| Gastrointestinal tract | 5 ± 11 | 6 ± 8 | 7 ± 9 | 6 ± 7 | 0.018 |
| Bone | 0 ± 5 | 0 ± 1 | 0 ± 1 | 0 ± 0 | 0.205 |
| Skin and soft tissue | 3 ± 11 | 3 ± 5 | 3 ± 4 | 3 ± 3 | 0.196 |
| Others | 2 ± 10 | 2 ± 6 | 2 ± 4 | 3 ± 6 | 0.177 |
| Proportion of APACHE II score ≥ 15, % | 57 ± 27 | 61 ± 24 | 65 ± 23 | 62 ± 24 | < 0.0001 |
| Hospital mortality of septic shock cases, % | 24 ± 26 | 24 ± 20 | 20 ± 17 | 18 ± 15 | < 0.0001 |
Data presented as mean ± SD, n (%). p value represents comparisons between all quartiles
Hospital bed days/1000 patients, days of hospital bed occupancy per 1000 patients
ICU bed days/1000 patients, days of ICU bed occupancy per 1000 patients
APACHE Acute physiology and chronic health evaluation, ICU intensive care unit
aComparisons between groups were made using the ANOVA test for continuous variables and the Chi-Squared test for categorical variables
Fig. 1Box plot of hospital-level rate of adherence to 3-h bundle showing median, interquartile range, range (with outliers), and median (diamonds). All quartiles compared to the lowest quartile (quartile 1 as reference)
Association between septic shock case volume quartile and hospital mortality of septic shock
| Sample | Unadjusted | Model 1 | Model 2 | Model 3 | Model 4 | Interaction |
|---|---|---|---|---|---|---|
| First quartile | Ref | Ref | Ref | Ref | Ref | – |
| Second quartile | − 0.35 (− 0.47, − 0.22) | − 0.30 (− 0.44, − 0.16) | − 0.29 (− 0.43, − 0.14) | − 0.28 (− 0.43, − 0.13) | − 0.29 (− 0.43, − 0.14) | < 0.001b |
| Third quartile | − 0.69 (− 0.81, − 0.56) | − 0.63 (− 0.78, − 0.49) | − 0.62 (− 0.77, − 0.47) | − 0.62 (− 0.77, − 0.47) | − 0.62 (− 0.77, − 0.47) | < 0.001c |
| Fourth Quartile | − 0.86 (− 0.98, − 0.74) | − 0.80 (− 0.95, − 0.66) | − 0.79 (− 0.95, − 0.64) | − 0.79 (− 0.94, − 0.64) | − 0.79 (− 0.94, − 0.64) | 0.037d |
Model 1, model adjusted for type of hospitals, geographic location, site of infection (sites of bloodstream, urinary, skin, central nervous system, lung, bone, abdominal, gastrointestinal), the proportion of APACHE II score ≥ 15, and proportion of age ≥ 60
Model 2, adjusted for model 1 + microbiology specimen collection before antibiotic therapy
Model 3, adjusted for model 2 + infection management, infection training, infection monitor, infection contingency plan, infection performance
Model 4, adjusted for model 3 + adherence to 3-h bundle
aInteraction p values comparisons of Model 4 between case volume quartiles were made using the Turkey's test
bComparison between second quartile and first quartile
cComparison between third quartile and second quartile
dComparison between fourth quartile and third quartile
Fig. 2Association of septic shock case volume and the ln(log)-transformed in-hospital mortality rate. Predictions of ln(log)-transformed in-hospital mortality rate are indicated by solid lines and 95% CI by shaded areas; dashed vertical line indicates the threshold before which an increase in volume resulted in a substantial reduction in estimated mortality. Knots were placed at 5th, 35th, 50th, 65th, and 95th centiles of septic shock case volume distribution. Model A was unadjusted (R2 0.141, p for nonlinearity < 0.0001). Model B was adjusted for type of hospitals, geographic location, adherence to 3-h SSC bundle, site of infection (sites of bloodstream, urinary, skin, central nervous system, lung, bone, abdominal, gastrointestinal), microbiology specimen collection before antibiotic therapy, infection management, infection training, infection monitor, infection contingency plan, infection performance, and the proportion of APACHE II score ≥ 15 and proportion of age ≥ 60 (R2 0.17, p for nonlinearity < 0.0001)